From Ivory Tower to Wall Street: Monetizing University Biotech Royalties
A scientist in a university lab toils over a breakthrough therapy. Years later, that discovery becomes a best-selling drug, delivering a steady stream of royalty income to the university.
Once regarded simply as a happy windfall, these royalty streams are now treated as strategic financial assets. Universities across the